Studies with a human plasma-derived immunosuppressive, anti-lymphoma factor

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• Human plasma contains various protein fractions with potential biological activities.
• Alpha-globulin concentrate is a source of bioactive molecules.
• Understanding factors that regulate cell proliferation is crucial for cancer and immunology research.

Purpose of the Study:

• To isolate and characterize a low-molecular-weight factor from human plasma alpha-globulin concentrate.
• To investigate the anti-proliferative effects of this factor on T cells and leukemia cells.
• To elucidate the mechanism of action and cellular targets of the isolated factor.

Main Methods:

• Isolation of the factor using acid-salt dissociation and ultrafiltration.
• Assessment of proliferation inhibition in mitogen-stimulated T cells and L1210 leukemia cells.
• Analysis of DNA, RNA, and protein synthesis inhibition.
• Cell cycle analysis to determine the phase of action.
• Investigation of the role of cyclic AMP (cAMP) and sulfhydryl compounds in factor activity.

Main Results:

• A low-molecular-weight factor (UM05R) was isolated from human plasma.
• UM05R demonstrated significant inhibition of T cell and L1210 leukemia cell proliferation.
• The factor inhibited DNA, RNA, and protein synthesis, acting in the G1 phase of the cell cycle.
• UM05R suppressed T cell proliferation independently of accessory cells.
• Factor activity was enhanced by cAMP-elevating agents and sulfhydryl compounds.

Conclusions:

• The plasma-derived factor UM05R possesses potent anti-proliferative properties against lymphocytes and leukemia cells.
• UM05R's mechanism involves the inhibition of essential macromolecular synthesis during the G1 phase.
• The observed enhancement of UM05R activity by cAMP-elevating agents supports a role for intracellular cAMP in its lympho-proliferative suppression.